The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer.

MLA

Strickland, Lincoln N., et al. “The Resurgence of the Adora2b Receptor as an Immunotherapeutic Target in Pancreatic Cancer.” Frontiers in Immunology, May 2023, pp. 1–15. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1163585.

APA

Strickland, L. N., Faraoni, E. Y., Wei Ruan, Xiaoyi Yuan, Eltzschig, H. K., & Bailey-Lundberg, J. M. (2023). The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer. Frontiers in Immunology, 1–15. https://doi.org/10.3389/fimmu.2023.1163585

Chicago

Strickland, Lincoln N., Erika Y. Faraoni, Wei Ruan, Xiaoyi Yuan, Holger K. Eltzschig, and Jennifer M. Bailey-Lundberg. 2023. “The Resurgence of the Adora2b Receptor as an Immunotherapeutic Target in Pancreatic Cancer.” Frontiers in Immunology, May, 1–15. doi:10.3389/fimmu.2023.1163585.